Business Wire
19 May 2026, 09:30 UTC · 2d ago
Source · https://www.businesswire.com/news/home/20260519752884/en/BioStar-Capital-Backed-Amplitude-Vascular-Systems%E2%80%99-835M-Acquisition-by-Stryker-Reflects-Strength-of-Michigan%E2%80%99s-Medtech-Ecosystem/
Read source
Search tags
Story key points
2 claims · impact-rated
Stryker (NYSE:SYK) has acquired Amplitude Vascular Systems (AVS) for up to $835 million. — A significant acquisition of next-generation medical technology expands Stryker's portfolio and market reach in treating calcified peripheral arterial disease.
+0.40BioStar Capital has completed a pre-FDA exit from its investment in Amplitude Vascular Systems. — While a positive outcome for the VC firm, it has minimal direct impact on broader public market indices.
+0.10Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company is expanding its medical technology portfolio through the strategic acquisition of Amplitude Vascular Systems.
No ticker relationship head found.
